Zhang et al. conducted a clinical study of CT-enhanced scans combined with targeted nanoparticle contrast agents (platelet-derived growth factor receptor-β, Ret and Kit bind to superparamagnetic iron oxide nanoparticles via covalent bonding) for the diagnosis of early gastric cancer. The gene discussed is KIT; the disease is gastric cancer.